Price T Rowe Associates Inc Guardant Health, Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GH
# of Institutions
322Shares Held
115MCall Options Held
738KPut Options Held
1.67M-
Vanguard Group Inc Valley Forge, PA11.7MShares$348 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$334 Million0.01% of portfolio
-
Baillie Gifford & CO5.87MShares$175 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$134 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$133 Million0.02% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.04B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...